Secondary Outcome(s)
|
Number of Participants With use of Concomitant Medications at Time of Infusion
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|
Number of Participants With use of Pre-infusion Medications
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|
Number of Participants With Subsequent Reactions After the First Infusion Reaction
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|
Number of Participants With Infusion Reaction Treatments
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|
Percentage of Participants With Relative Change of at Least 50 Percent (%) and a Maximum Score of 2 in RAID Score
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|
Change From Baseline in Rheumatoid Arthritis Impact of Disease (RAID) Score
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|
Percentage of Participants With Absolute Change of at Least 3 Points in RAID Score
[Time Frame: Baseline up to end of study (2 years) or early withdrawal]
|